Bactiguard has entered an exclusive distribution agreement for Israel with Dover Medical & Scientific Equipment Ltd. The agreement covers sales of all products in the Bactiguard Infection Protection portfolio.
“Changing our market strategy for Israel from direct sales to sales via a distributor is a more cost efficient way of expanding our presence and sales in this market. The number of patients that die from infections caused by resistant bacteria in Israeli hospitals is estimated to more than 4 000 per year, so there is a great need for preventive solutions”, says Niels Christiansen, CEO.
Israel has a population of 8 million people and almost 8 percent of GDP is spent on healthcare. Offering preventive solutions, such as Bactiguard® -coated catheters for the urinary- and respiratory tracts and the bloodstream is vital to combat healthcare associated infections.
The distributor in Israel, Dover Medical & Scientific Equipment, Ltd., is a family owned company founded in 1974. It is one of the leading companies in the Israeli market for medical devices with customers such as: Ministry of Health Hospitals, University Hospitals, Private Hospitals, Clinics and Research Institutes. Dover focuses on medical and diagnostic solutions.
For further information, please contact:
Cecilia Edström, Acting Director of Sales, Marketing & Communications, mobile: +46 722 262 328